Type: (null)
Journal: Journal of Clinical Oncology
Year: 2016
Pages: 34, 1500-1509
Docetaxel As Monotherapy or Combined With Ramucirumab or Icrucumab in Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: An Open-Label, Three-Arm, Randomized Controlled Phase II Trial
Distribution of the number of citations over years.

Authors

#AuthorsArticlesCitationsh-index
1Scott T Tagawa13014660130
2Andrea Eisen53197553
3Jeanny B Aragon-ching1183602118
4David I Quinn24618828246